Background. The effectiveness of nucleoside analogue (NA) treatment in patients with chronic hepatitis B (CHB)-associated liver failure is still controversial. Severe lactic acidosis has been reported during enteca-vir (ETV) treatment in patients with impaired liver function. Aim. To investigate the rescuing efficacy and safety of ETV in patients with CHB-associated liver failure. Material and methods. A literature search was carried out to collect articles dated up to December, 2013 on ETV therapy for patients with CHB-associa-ted liver failure. Risk ratio (RR) and mean difference (MD) were used to measure the effects. Survival rate was used as the primary efficacy measure. The safety of ETV was assessed. Results. Six randomized contro-lle...
WOS: 000347840000016PubMed: 25790537Background/aim: To evaluate the efficacy of entecavir (ETV) amon...
Background & Aims: Entecavir is a potent inhibitor of viral replication in nucleos(t)ide analogu...
BACKGROUND & AIMS: Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent antiviral ...
Background. The effectiveness of nucleoside analogue (NA) treatment in patients with chronic hepatit...
The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated liver failu...
The purpose of this study was to compare the efficacy of nucleoside analogues (NAs) in the treatment...
PURPOSE: The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated li...
Current guidelines for management of chronic hepatitis B recommend treatment for patients presenting...
ObjectiveTo evaluate the efficacy of entecavir treatment up to 96 weeks for patients with chronic he...
Background: Entecavir (ETV) has been shown to be effective in randomized controlled trials in highly...
Background: Lamivudine has been widely used in chronic hepatitis B patients with hepatic decompensat...
Background. Currently, both of entecavir and lamivudine are effective for patients with HBV-associat...
Aim: The efficacy of entecavir (ETV) in treatment-experienced chronic hepatitis B (CHB) patients rem...
Background and aims. Entecavir (ETV) is effective and safe in patients with chronic hepatitis B in t...
Background/Aims: Spontaneous acute exacerbation of chronic hepatitis B virus (HBV) infection occasio...
WOS: 000347840000016PubMed: 25790537Background/aim: To evaluate the efficacy of entecavir (ETV) amon...
Background & Aims: Entecavir is a potent inhibitor of viral replication in nucleos(t)ide analogu...
BACKGROUND & AIMS: Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent antiviral ...
Background. The effectiveness of nucleoside analogue (NA) treatment in patients with chronic hepatit...
The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated liver failu...
The purpose of this study was to compare the efficacy of nucleoside analogues (NAs) in the treatment...
PURPOSE: The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated li...
Current guidelines for management of chronic hepatitis B recommend treatment for patients presenting...
ObjectiveTo evaluate the efficacy of entecavir treatment up to 96 weeks for patients with chronic he...
Background: Entecavir (ETV) has been shown to be effective in randomized controlled trials in highly...
Background: Lamivudine has been widely used in chronic hepatitis B patients with hepatic decompensat...
Background. Currently, both of entecavir and lamivudine are effective for patients with HBV-associat...
Aim: The efficacy of entecavir (ETV) in treatment-experienced chronic hepatitis B (CHB) patients rem...
Background and aims. Entecavir (ETV) is effective and safe in patients with chronic hepatitis B in t...
Background/Aims: Spontaneous acute exacerbation of chronic hepatitis B virus (HBV) infection occasio...
WOS: 000347840000016PubMed: 25790537Background/aim: To evaluate the efficacy of entecavir (ETV) amon...
Background & Aims: Entecavir is a potent inhibitor of viral replication in nucleos(t)ide analogu...
BACKGROUND & AIMS: Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent antiviral ...